Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 16/20 | 0.46 |
| ▸ | KDR | P35968 | 7/20 | 0.46 |
| ▸ | JAK3 | P52333 | 5/20 | 0.46 |
| ▸ | MAPK14 | Q16539 | 5/20 | 0.46 |
| ▸ | DHFR | P00374 | 2/20 | 0.43 |
| ▸ | KIT | P10721 | 8/20 | 0.40 |
| ▸ | SRC | P12931 | 8/20 | 0.40 |
| ▸ | TEK | Q02763 | 3/20 | 0.39 |
| ▸ | BRAF | P15056 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5496279 | 0.95 | LCK (0.51) | LCKKDRJAK3MAPK14DHFR | |
| Bicarbonate SCHEMBL5494584 | 0.81 | MAPT (0.37) | DHFRLMNAMAPT | |
| SCHEMBL5492624 | 0.78 | LCK (0.59) | LCKKDRJAK3MAPK14DHFR | |
| SCHEMBL5498336 | 0.73 | LCK (0.56) | LCKKDRJAK3MAPK14KIT | |
| SCHEMBL5494437 | 0.71 | LCK (0.60) | LCKKDRJAK3MAPK14TEK | |
| SCHEMBL5502206 | 0.71 | LCK (0.58) | LCKKDRJAK3MAPK14KIT | |
| SCHEMBL1438547 | 0.70 | MAPT (0.51) | LMNAMAPT | |
| SCHEMBL5502492 | 0.70 | LCK (0.67) | LCKKDRJAK3MAPK14KIT | |
| SCHEMBL5490496 | 0.69 | LCK (0.62) | LCKKDRJAK3MAPK14TEK | |
| Benzene SCHEMBL27889154 | 0.68 | MAPT (0.49) | LCKKDRJAK3MAPK14LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1836174-A2 | ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS | AMGEN INC. (US) | 2007-09-26 | — | — | EP | disclosed |
| WO-2006039718-A2 | ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS | AMGEN INC (US) | 2006-04-13 | — | — | WO | disclosed |